Skip to main content

Burn Injury

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
1
dl-alpha-tocopheryl acetatePhase 11 trial
Active Trials
NCT01413620Withdrawn0Est. Aug 2021
Integra LifeSciences
Integra LifeSciencesAustralia - Clayton
1 program
Tissue Quality of Integra vs. BTM Treated BurnsN/A1 trial
Active Trials
NCT06760611Withdrawn0Est. Sep 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Oregon Therapeuticsdl-alpha-tocopheryl acetate
Integra LifeSciencesTissue Quality of Integra vs. BTM Treated Burns

Clinical Trials (2)

NCT01413620Oregon Therapeuticsdl-alpha-tocopheryl acetate

Vitamin E Supplementation in Burn Patients

Start: Aug 2011Est. completion: Aug 20210
Phase 1Withdrawn
NCT06760611Integra LifeSciencesTissue Quality of Integra vs. BTM Treated Burns

Tissue Quality of Integra vs. BTM Treated Burns

Start: Mar 2025Est. completion: Sep 20250
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.